Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating cardiovascular risks in coeliac disease patients

Official title: Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies

Run by University of Pecs · NCT05530070 · Data updated 2026-11-12

This study is testing how a gluten-free diet affects heart health in people with coeliac disease and whether a special eating plan can help improve their cardiovascular risks.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment190 (estimated)
SponsorUniversity of Pecs
Academic / other
Locations1 site (Pécs, Baranya)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedJanuary 22, 2025
Trial IDNCT05530070 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years with a confirmed diagnosis of coeliac disease, either newly diagnosed or those on a gluten-free diet for at least one year.

Probably not a fit

Patients who are not diagnosed with coeliac disease or those who do not adhere to a gluten-free diet may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This investigation examines key cardiovascular risk factors and their changes in patients with coeliac disease. It assesses body composition and metabolic parameters in newly diagnosed and treated coeliac patients, focusing on the impact of a gluten-free diet. The study includes a randomized controlled trial to evaluate whether a structured dietary intervention can mitigate the adverse effects associated with an unbalanced diet. The research aims to provide insights into the cardiovascular health of coeliac patients and the effectiveness of dietary management.

Why it matters

Potential benefit: If successful, this study could lead to improved dietary guidelines that reduce cardiovascular risks for patients with coeliac disease.

How similar studies have gone: While there is limited information on cardiovascular risks in coeliac disease, similar dietary interventions have shown promise in managing metabolic parameters in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (applies to all subjects):

* Age should be over 18 years.
* Blood collection must be indicated with medical conditions.
* Signed informed consent.

Inclusion Criteria (applies to specific cohorts of patients):

* The diagnosis of CD should be set up according to the current guidelines (based on serology and histology in adults or as per the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guideline in children).
* The newly diagnosed CD patients should be on a gluten-containing diet.
* Patients following a GFD for at least 1 year should exhibit good dietary adherence.
* In the randomized controlled trial (RCT), strict dietary adherence will be established based on CD-specific serology (normal level of antibodies), urine gluten immunogenic peptides (negative urine test), and dietary interview (convincing knowledge on the GFD and positive attitude towards strict adherence). Adherence to the mediterranean diet should be suboptimal (≤ 8 Medietrranean Diet Score). RCT-patients must have internet access and must be capable to attend the online sessions for 1 year.
* Control subjects should be free from CD according to the recent guidelines and should be on a gluten-containing diet.

Exclusion Criteria:

* Chronic conditions:

  * Estimated glomerular filtration rate calculated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula is \<60mL/min/1.73m2 (CKD3 or more severe kidney failure).
  * Liver cirrhosis in Child-Pugh class B-C.
  * Heart failure (New York Heart Association (NYHA) III-IV).
  * Active malignant diseases.
* Any acute diseases or acute deterioration of underlying chronic conditions.
* Diseases that may be associated with clinically relevant malabsorption.
* Refractory CD.
* Pregnancy, lactation.
* Patients unable to understand the essentials of the informed consent.
* Lack of consent or withdrawal of consent.

Where it's running

  • First Department of Medicine, Medical School, University of Pécs
    Pécs, Baranya, Hungary
    Recruiting

Study contacts

  • Principal investigator: Judit Bajor, MD, PhD — Division of Gastroenterology, First Department of Medicine, University of Pécs, 7624 Pécs, Hungary
  • Study coordinator: Judit Bajor, MD, PhD
  • Email: bajor.judit@pte.hu
  • Phone: +36 72 536 000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.